Experience

• 

  Tulsi pharmacy

  Feb 2008 - Jul 2010

  Pharmacy intern
• 

  Ramkumar medicals

  Sept 2010 - Aug 2011

  Consultant pharmacist
• 

  Natco pharma

  Jan 2011 - Aug 2011

  Medical representative
• 

  Kmch cop

  Oct 2011 - Oct 2013

  Research study assistant
• 

  Vettukad neethi pharmacy

  Nov 2013 - Dec 2013

  Consultant pharmacist

  In the capacity of fulfilling the request of Asharikad Co-operative Bank, Thrissur, Alex Thomas took on the responsibility of establishing a fully functional pharmacy. His job profile encompassed a comprehensive range of tasks, including identifying the need for the pharmacy, conducting feasibility assessments, procuring necessary licenses, and designing the layout of the space. Alex liaised with pharmaceutical suppliers, ensured regulatory compliance, and played a pivotal role in assembling a skilled team to run the pharmacy efficiently. His dedication to creating a valuable healthcare resource within the bank's premises highlights his ability to translate vision into reality. Show less

• 

  Apollo hospitals

  Jan 2014 - Feb 2014

  Clinical pharmacist intern
• 

  Grace college of pharmacy, athalur, kodunthirappally

  Feb 2014 - Mar 2014

  Assistant professor
• 

  Confederation for ayurvedic renaissance (care) keralam ltd.(funded by ministry of ayush )

  Apr 2014 - Dec 2015

  Study director - toxicology, i/c dept. of toxicology

  He embarked on his professional journey as a Toxicologist at CARe Keralam Ltd., dedicating himself wholeheartedly to all facets of a research laboratory.His role encompassed diverse responsibilities, including customer interactions, determining study costs, formulating and reviewing study plans, conducting toxicological experiments in rodents, designing animal models for ailments like diabetes, ulcers, myocardial infarctions, and hepatoprotection. He was also engaged in statistical analyses, report preparation, blood collection, necropsy procedures, as well as managing and calibrating biochemical and hematology analyzers. His tasks extended to lyophilization, overseeing the animal housing facility, which included IVC cages, rat breeding and sales, organizing IAEC meetings, maintaining essential documents, crafting SOPs, and providing guidance to project students and trainees. Show less

• 

  International institute of biotechnology and toxicology (iibat)

  Jan 2016 - Nov 2017

  Study director - toxicology

  In January 2016, he joined IIBAT as a Study Director responsible for overseeing short and long-term toxicity studies. During his time at IIBAT, he significantly enhanced his expertise in GLP and Toxicology. Collaborative interactions across departments at IIBAT enriched his understanding across various branches of environmental toxicology.The International Institute of Bio-Technology and Toxicology (IIBAT) plays a crucial role as a bridge between the Industry and Regulatory Systems by furnishing GLP-based non-clinical health and environmental safety data. This data encompasses crop care/protection agents, formulations, biocides, household pest control chemicals, public health pest control agents, industrial chemicals, herbal/phyto molecules, plant growth regulators, clinical and veterinary medicines, transgenic crops/foods, r-DNA, biopharmaceuticals, and biotech products, all aimed at facilitating risk assessment.At IIBAT, research adheres to the standards and guidelines set forth by organizations such as OECD, KCR, ICH, OPPTS, Schedule Y, and other relevant bodies. With cutting-edge facilities and a team of highly experienced scientists, IIBAT produces quality reports that have a global impact. Show less

• 

  Sugen_ bioneeds

  Nov 2017 - Aug 2019

  Deputy director/hod/study director - toxicology/biocompatibility

  Toxicology/Biocompatibility

• 

  Cipla

  Aug 2019 - now

  Regulatory toxicologist

  He is involved in assisting with Integrated Product Development at Cipla, focusing on areas such as non-clinical pharmaceutical toxicology, impurity qualification, extractable and leachable assessment, health-based exposure limits (PDE and OEL), pharmacokinetics/pharmacodynamic research of new chemical entities (NCE) and pharmaceuticals, as well as 505(b)(2) applications, among other domains.